Author: | FDA, Biopharma Advantage Consulting L.L.C., eRegs And Guides Biopharma Advantage Consulting L.L.C. | ISBN: | 1230000220424 |
Publisher: | Biopharma Advantage Consulting L.L.C. | Publication: | February 22, 2014 |
Imprint: | Language: | English |
Author: | FDA, Biopharma Advantage Consulting L.L.C., eRegs And Guides Biopharma Advantage Consulting L.L.C. |
ISBN: | 1230000220424 |
Publisher: | Biopharma Advantage Consulting L.L.C. |
Publication: | February 22, 2014 |
Imprint: | |
Language: | English |
PART 600 BIOLOGICAL PRODUCTS: GENERAL
PART 601 LICENSING
PART 606 CURRENT GOOD MANUFACTURING PRACTICE FOR BLOOD AND BLOOD COMPONENTS
PART 607 ESTABLISHMENT REGISTRATION AND PRODUCT LISTING FOR MANUFACTURERS OF HUMAN BLOOD AND BLOOD PRODUCTS
PART 610 GENERAL BIOLOGICAL PRODUCTS STANDARDS
PART 630 GENERAL REQUIREMENTS FOR BLOOD, BLOOD COMPONENTS, AND BLOOD DERIVATIVES
PART 640 ADDITIONAL STANDARDS FOR HUMAN BLOOD AND BLOOD PRODUCTS
PART 660 ADDITIONAL STANDARDS FOR DIAGNOSTIC SUBSTANCES FOR LABORATORY TESTS
PART 680 ADDITIONAL STANDARDS FOR MISCELLANEOUS PRODUCTS
PART 1270 HUMAN TISSUE INTENDED FOR TRANSPLANTATION
PART 1271 HUMAN CELLS, TISSUES, AND CELLULAR AND TISSUE-BASED PRODUCTS
Guidance for Industry: Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products
PART 600 BIOLOGICAL PRODUCTS: GENERAL
PART 601 LICENSING
PART 606 CURRENT GOOD MANUFACTURING PRACTICE FOR BLOOD AND BLOOD COMPONENTS
PART 607 ESTABLISHMENT REGISTRATION AND PRODUCT LISTING FOR MANUFACTURERS OF HUMAN BLOOD AND BLOOD PRODUCTS
PART 610 GENERAL BIOLOGICAL PRODUCTS STANDARDS
PART 630 GENERAL REQUIREMENTS FOR BLOOD, BLOOD COMPONENTS, AND BLOOD DERIVATIVES
PART 640 ADDITIONAL STANDARDS FOR HUMAN BLOOD AND BLOOD PRODUCTS
PART 660 ADDITIONAL STANDARDS FOR DIAGNOSTIC SUBSTANCES FOR LABORATORY TESTS
PART 680 ADDITIONAL STANDARDS FOR MISCELLANEOUS PRODUCTS
PART 1270 HUMAN TISSUE INTENDED FOR TRANSPLANTATION
PART 1271 HUMAN CELLS, TISSUES, AND CELLULAR AND TISSUE-BASED PRODUCTS
Guidance for Industry: Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products